2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid

C139H165BrN16O32S9 — CID 160745003

About 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid

2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid (PubChem CID 160745003) has the molecular formula C139H165BrN16O32S9 and a molecular weight of 2940.44 g/mol. Its IUPAC name is 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid.

Molecular Properties

• Compound Name: 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid
• PubChem CID: 160745003
• Molecular Formula: C139H165BrN16O32S9
• Molecular Weight: 2940.44 g/mol
• Exact Mass: 2936.84
• IUPAC Name: 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid
• SMILES: C=S1(=O)CCC(O[C@@H](Cc2nn(C(C)(C)C(=O)O)c(=O)c3c(C)c(-c4ncco4)sc23)c2ccccc2OC)CC1.COc1ccccc1[C@H](CC1=NN(C(C)(C)C(=O)O)S(=O)(=O)c2c1sc(-c1ncco1)c2C)OC1CCCCC1.COc1ccccc1[C@H](CC1=NN(C(C)(C)C(N)=O)S(=O)(=O)c2c1sc(-c1ncco1)c2C)OC1CCCCC1.COc1ccccc1[C@H](CN1c2sc(Br)c(C)c2C(=O)N(C(C)(C)C(=O)O)S1(=O)=O)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(N)=O)c(=O)c2c(C)c(-c3ncco3)sc12)OC1CCCCC1
• InChI: InChI=1S/C29H34N4O5S.C29H33N3O7S2.C28H34N4O6S2.C28H33N3O7S2.C25H31BrN2O7S2/c1-17-23-25(39-24(17)26-31-14-15-37-26)20(32-33(27(23)34)29(2,3)28(30)35)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-17-23-25(40-24(17)26-30-12-13-38-26)20(31-32(27(23)33)29(2,3)28(34)35)16-22(19-8-6-7-9-21(19)37-4)39-18-10-14-41(5,36)15-11-18;1-17-23(26-30-14-15-37-26)39-24-20(31-32(28(2,3)27(29)33)40(34,35)25(17)24)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-17-23(26-29-14-15-37-26)39-24-20(30-31(28(2,3)27(32)33)40(34,35)25(17)24)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-15-20-22(29)28(25(2,3)24(30)31)37(32,33)27(23(20)36-21(15)26)14-19(35-16-10-6-5-7-11-16)17-12-8-9-13-18(17)34-4/h8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H2,30,35);6-9,12-13,18,22H,5,10-11,14-16H2,1-4H3,(H,34,35);8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H2,29,33);8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H,32,33);8-9,12-13,16,19H,5-7,10-11,14H2,1-4H3,(H,30,31)/t22-;18?,22-,41?;2*22-;19-/m00000/s1
• InChIKey: RWBWYQMENRJDHC-JBGGPPHZSA-N
• XLogP: 25.95
• TPSA: 638.52 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 44
• Rotatable Bonds: 44
• Heavy Atoms: 197
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2940.44
LogP ≤ 5	25.95
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	44

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid?

The IUPAC name of 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid (CID 160745003) is 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid.

What is the SMILES notation for 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid?

The canonical SMILES for 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid is C=S1(=O)CCC(O[C@@H](Cc2nn(C(C)(C)C(=O)O)c(=O)c3c(C)c(-c4ncco4)sc23)c2ccccc2OC)CC1.COc1ccccc1[C@H](CC1=NN(C(C)(C)C(=O)O)S(=O)(=O)c2c1sc(-c1ncco1)c2C)OC1CCCCC1.COc1ccccc1[C@H](CC1=NN(C(C)(C)C(N)=O)S(=O)(=O)c2c1sc(-c1ncco1)c2C)OC1CCCCC1.COc1ccccc1[C@H](CN1c2sc(Br)c(C)c2C(=O)N(C(C)(C)C(=O)O)S1(=O)=O)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(N)=O)c(=O)c2c(C)c(-c3ncco3)sc12)OC1CCCCC1.

What is the InChIKey of 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid?

The InChIKey is RWBWYQMENRJDHC-JBGGPPHZSA-N. The full InChI is InChI=1S/C29H34N4O5S.C29H33N3O7S2.C28H34N4O6S2.C28H33N3O7S2.C25H31BrN2O7S2/c1-17-23-25(39-24(17)26-31-14-15-37-26)20(32-33(27(23)34)29(2,3)28(30)35)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-17-23-25(40-24(17)26-30-12-13-38-26)20(31-32(27(23)33)29(2,3)28(34)35)16-22(19-8-6-7-9-21(19)37-4)39-18-10-14-41(5,36)15-11-18;1-17-23(26-30-14-15-37-26)39-24-20(31-32(28(2,3)27(29)33)40(34,35)25(17)24)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-17-23(26-29-14-15-37-26)39-24-20(30-31(28(2,3)27(32)33)40(34,35)25(17)24)16-22(38-18-10-6-5-7-11-18)19-12-8-9-13-21(19)36-4;1-15-20-22(29)28(25(2,3)24(30)31)37(32,33)27(23(20)36-21(15)26)14-19(35-16-10-6-5-7-11-16)17-12-8-9-13-18(17)34-4/h8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H2,30,35);6-9,12-13,18,22H,5,10-11,14-16H2,1-4H3,(H,34,35);8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H2,29,33);8-9,12-15,18,22H,5-7,10-11,16H2,1-4H3,(H,32,33);8-9,12-13,16,19H,5-7,10-11,14H2,1-4H3,(H,30,31)/t22-;18?,22-,41?;2*22-;19-/m00000/s1.

What are the key properties of 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid?

2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid has a molecular weight of 2940.44 g/mol, XLogP of 25.95, 44 rotatable bonds, 5 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[6-bromo-1-[(2R)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-5-methyl-2,2,4-trioxothieno[2,3-c][1,2,6]thiadiazin-3-yl]-2-methylpropanoic acid;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanamide;2-[4-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-7-methyl-6-(1,3-oxazol-2-yl)-1,1-dioxothieno[2,3-e]thiadiazin-2-yl]-2-methylpropanoic acid;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-(2-methoxyphenyl)-2-(1-methylidene-1-oxothian-4-yl)oxyethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxothieno[2,3-d]pyridazin-5-yl]-2-methylpropanoic acid is sourced from PubChem (CID 160745003), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).